In 2021, Julie served as a stakeholder engager for a qualitative investigation on COVID-19 vaccine hesitancy in neurodivergent communities, with the goal of increasing public health efforts towards increasing vaccine confidence among this population. The manuscript recently got published, which can be accessed here. In this role, she and a team of other stakeholder engagers interviewed medical professionals, those in the neurodivergent community, and their caregivers to better understand the...
